Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,428 | N/A | N/A | N/A | N/A |
| Receivables | 8 | N/A | N/A | N/A | N/A |
| TOTAL | $52,904 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 509 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 1,376 | 0 | 0 | 0 | 0 |
| TOTAL | $1,885 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $54,789 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,576 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 1,602 | N/A | N/A | N/A | N/A |
| TOTAL | $3,991 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 813 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 561 | 0 | 0 | 0 | 0 |
| TOTAL | $7,760 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,751 | $N/A | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,226 | N/A | N/A | N/A | N/A |
| Retained earnings | -18,069 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 59,569 | 0 | 0 | 0 | 0 |
| TOTAL | $43,038 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $54,789 | $0 | $0 | $0 | $0 |